The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MagnetisMM-5: An open-label, multicenter, randomized phase 3 study of elranatamab as monotherapy and in combination with daratumumab in patients with relapsed/refractory multiple myeloma.
 
Sebastian Grosicki
No Relationships to Disclose
 
Jacob Crafoord
No Relationships to Disclose
 
Youngil Koh
No Relationships to Disclose
 
Darrel White
Honoraria - Amgen; Antengene; Bristol-Myers Squibb; Forus; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
 
Ulf-Henrik Mellqvist
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Sandoz; Sanofi
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Sandoz; Sanofi
 
Eric Leip
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Arthur Kudla
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Gregory Finn
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Łukasz Pruchniewski
No Relationships to Disclose